THYROID EYE DISEASE

This study is testing an investigational drug called IBI311 for people with inactive thyroid eye disease, a condition that can cause the eyes to bulge forward. About 111 participants will be randomly assigned to receive either the drug or a placebo to see if IBI311 can safely red…

This study is testing an experimental injection called AMG 732 for people with moderate-to-severe thyroid eye disease, which causes painful, bulging eyes. The research has two parts: first checking safety in healthy volunteers, then testing if the treatment reduces eye bulging an…

This early-stage study is testing the safety of an oral medication called K9 for people with active Thyroid Eye Disease (TED). Up to 10 patients will take the pill twice daily for up to 24 weeks, with doctors closely monitoring for side effects. The study will also track changes …

This study is testing a medication called Teprotumumab N01 for people with active Thyroid Eye Disease (TED), a condition that causes eye bulging, double vision, and swelling. Fifty participants will receive the drug and have their eye symptoms and quality of life tracked for 24 w…

This study is testing whether two different doses of an experimental medication called TOUR006 can help people with active thyroid eye disease. Participants receive injections every eight weeks and are compared against a placebo group. The main goal is to see if the treatment red…

This study aims to understand how the body processes and breaks down a common anti-inflammatory steroid medication called prednisolone when given at high doses. Researchers will measure drug levels in the blood and urine of 120 patients who are taking high doses of prednisolone f…